Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-20

Clinical Trial Update: High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease

View source ↗

Summary

A completed clinical trial evaluated high-dose esomeprazole in combination with baclofen for treating gastroesophageal reflux disease in patients with persisten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)
  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: Technical University of Munich | Conditions: Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole | Status: COMPLETED